Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.
Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL, Kawai A, Leithner A, Loong H, Mascard E, Morosi C, Otten N, Palmerini E, Patel SR, Reichardt P, Rubin B, Rutkowski P, Sangalli C, Schuster K, Seddon BM, Shkodra M, Staals EL, Tap W, van de Rijn M, van Langevelde K, Vanhoenacker FMM, Wagner A, Wiltink L, Stern S, Van de Sande VM, Bauer S.
Cancer Treat Rev. 2023 Jan;112:102491. doi: 10.1016/j.ctrv.2022.102491. Epub 2022 Dec 6.
MANEUVER: A Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patients.
Niu X, Ravi V, Shan B, Guo Q, Shi H, Zou Q, Gelderblom H.
Future Oncol. 2024 Sep 17:1-8. doi: 10.1080/14796694.2024.2396227. Online ahead of print.
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Rüttinger D.
J Immunother Cancer. 2017 Jul 18;5(1):53. doi: 10.1186/s40425-017-0257-y.
Tenosynovial giant cell tumor of cruciate ligament: A case report and review.
Tu NV, Quyen NVS, Ngoc MH, Trung HP, Nguyen BS, Trung DT.
Int J Surg Case Rep. 2022 Feb;91:106771. doi: 10.1016/j.ijscr.2022.106771. Epub 2022 Jan 15.
Localized tenosynovial giant cell tumor in children.
Du X, Xia A, Sun J, Ye Y.
J Child Orthop. 2023 Jul 13;17(5):420-427. doi: 10.1177/18632521231186795. eCollection 2023 Oct.
Treatment updates on tenosynovial giant cell tumor.
Palmerini E, Staals EL.
Curr Opin Oncol. 2022 Jul 1;34(4):322-327. doi: 10.1097/CCO.0000000000000853.
Treatment Modalities for Refractory-Recurrent Tenosynovial Giant Cell Tumor (TGCT): An Update.
Dania V, Stavropoulos NA, Gavriil P, Trikoupis I, Koulouvaris P, Savvidou OD, Mavrogenis AF, Papagelopoulos PJ.
Medicina (Kaunas). 2024 Oct 12;60(10):1675. doi: 10.3390/medicina60101675.
Diffuse-Type Tenosynovial Giant Cell Tumor An Update of Current Management Strategies.
Naja A, Abboud A, Masrouha K, Ghert M, Saghieh S.
Bull Hosp Jt Dis (2013). 2024 Sep;82(3):178-185.
Single-Cell Analysis Clarifies Pathological Heterogeneity in Tenosynovial Giant Cell Tumor and Identifies Biomarkers for Predicting Disease Recurrence.
Xie Y, Chen C, Wu F, Peng Y, Su J, Zhao Y, Huang H, Li ZA, Pei Y, Li W, He Y, Xue T, Cao C, Peng S, Zhang X, Song W.
Adv Sci (Weinh). 2025 Jul;12(26):e2415835. doi: 10.1002/advs.202415835. Epub 2025 Mar 24.
Tenosynovial giant cell tumor: case report and review.
Lucas DR.
Arch Pathol Lab Med. 2012 Aug;136(8):901-6. doi: 10.5858/arpa.2012-0165-CR.
